Gojo, Javelle B.

HRN: 28-18-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/27/2025
01/02/2026
IVT
200mg
Q8
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines